STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 98 filers reported holding STOKE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.14 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $245,300 | -54.8% | 62,259 | +21.9% | 0.00% | -42.9% |
Q2 2023 | $542,917 | +25.5% | 51,074 | -1.7% | 0.01% | 0.0% |
Q1 2023 | $432,635 | +107.4% | 51,937 | +129.8% | 0.01% | +75.0% |
Q4 2022 | $208,635 | -71.9% | 22,604 | -60.9% | 0.00% | -69.2% |
Q3 2022 | $743,000 | -3.5% | 57,864 | -0.8% | 0.01% | -7.1% |
Q2 2022 | $770,000 | -93.5% | 58,309 | -89.7% | 0.01% | -87.3% |
Q1 2022 | $11,883,000 | -53.8% | 564,516 | -47.4% | 0.11% | -24.7% |
Q4 2021 | $25,728,000 | -10.0% | 1,072,440 | -4.5% | 0.15% | -1.4% |
Q3 2021 | $28,578,000 | -31.9% | 1,123,355 | -9.8% | 0.15% | -28.2% |
Q2 2021 | $41,939,000 | -14.7% | 1,245,956 | -1.6% | 0.21% | -22.3% |
Q1 2021 | $49,169,000 | -46.0% | 1,265,950 | -13.9% | 0.26% | -41.4% |
Q4 2020 | $91,089,000 | +82.5% | 1,470,841 | -1.3% | 0.45% | +46.8% |
Q3 2020 | $49,905,000 | +33.4% | 1,490,153 | -5.1% | 0.31% | +5.1% |
Q2 2020 | $37,403,000 | -3.2% | 1,569,564 | -6.9% | 0.29% | -36.7% |
Q1 2020 | $38,627,000 | -25.3% | 1,686,747 | -7.7% | 0.46% | -13.8% |
Q4 2019 | $51,738,000 | +28.3% | 1,826,890 | -2.6% | 0.54% | +16.0% |
Q3 2019 | $40,319,000 | -25.8% | 1,876,191 | +0.8% | 0.46% | -15.5% |
Q2 2019 | $54,304,000 | – | 1,861,623 | – | 0.55% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ATP Life Science Ventures, L.P. | 16,786,713 | $562,187,000 | 75.80% |
RTW INVESTMENTS, LP | 3,544,248 | $118,697,000 | 2.86% |
Cormorant Asset Management, LP | 1,537,807 | $51,501,000 | 1.98% |
Redmile Group, LLC | 2,549,506 | $85,383,000 | 1.57% |
Birchview Capital, LP | 40,000 | $1,340,000 | 0.45% |
HighVista Strategies LLC | 17,082 | $572,000 | 0.42% |
Perceptive Advisors | 671,978 | $22,505,000 | 0.33% |
GILDER GAGNON HOWE & CO LLC | 1,490,153 | $49,905,000 | 0.31% |
Artal Group S.A. | 270,750 | $9,067,000 | 0.22% |
VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 323 | $11,000 | 0.20% |